Cargando…
A case of a patient receiving combination therapy with paclitaxel plus bevacizumab and adoptive activated αβ T‐cell immunotherapy in advanced breast cancer
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839766/ https://www.ncbi.nlm.nih.gov/pubmed/33277749 http://dx.doi.org/10.1111/tbj.14108 |
| _version_ | 1783643451799109632 |
|---|---|
| author | Masuda, Takaaki Nonami, Atsushi Tanaka, Fumiaki Ando, Yuki Eto, Masatoshi Mimori, Koshi |
| author_facet | Masuda, Takaaki Nonami, Atsushi Tanaka, Fumiaki Ando, Yuki Eto, Masatoshi Mimori, Koshi |
| author_sort | Masuda, Takaaki |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7839766 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78397662021-02-02 A case of a patient receiving combination therapy with paclitaxel plus bevacizumab and adoptive activated αβ T‐cell immunotherapy in advanced breast cancer Masuda, Takaaki Nonami, Atsushi Tanaka, Fumiaki Ando, Yuki Eto, Masatoshi Mimori, Koshi Breast J Commentaries John Wiley and Sons Inc. 2020-12-05 2020-12 /pmc/articles/PMC7839766/ /pubmed/33277749 http://dx.doi.org/10.1111/tbj.14108 Text en © 2020 The Authors. The Breast Journal published by Wiley Periodicals LLC This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Commentaries Masuda, Takaaki Nonami, Atsushi Tanaka, Fumiaki Ando, Yuki Eto, Masatoshi Mimori, Koshi A case of a patient receiving combination therapy with paclitaxel plus bevacizumab and adoptive activated αβ T‐cell immunotherapy in advanced breast cancer |
| title | A case of a patient receiving combination therapy with paclitaxel plus bevacizumab and adoptive activated αβ T‐cell immunotherapy in advanced breast cancer |
| title_full | A case of a patient receiving combination therapy with paclitaxel plus bevacizumab and adoptive activated αβ T‐cell immunotherapy in advanced breast cancer |
| title_fullStr | A case of a patient receiving combination therapy with paclitaxel plus bevacizumab and adoptive activated αβ T‐cell immunotherapy in advanced breast cancer |
| title_full_unstemmed | A case of a patient receiving combination therapy with paclitaxel plus bevacizumab and adoptive activated αβ T‐cell immunotherapy in advanced breast cancer |
| title_short | A case of a patient receiving combination therapy with paclitaxel plus bevacizumab and adoptive activated αβ T‐cell immunotherapy in advanced breast cancer |
| title_sort | case of a patient receiving combination therapy with paclitaxel plus bevacizumab and adoptive activated αβ t‐cell immunotherapy in advanced breast cancer |
| topic | Commentaries |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839766/ https://www.ncbi.nlm.nih.gov/pubmed/33277749 http://dx.doi.org/10.1111/tbj.14108 |
| work_keys_str_mv | AT masudatakaaki acaseofapatientreceivingcombinationtherapywithpaclitaxelplusbevacizumabandadoptiveactivatedabtcellimmunotherapyinadvancedbreastcancer AT nonamiatsushi acaseofapatientreceivingcombinationtherapywithpaclitaxelplusbevacizumabandadoptiveactivatedabtcellimmunotherapyinadvancedbreastcancer AT tanakafumiaki acaseofapatientreceivingcombinationtherapywithpaclitaxelplusbevacizumabandadoptiveactivatedabtcellimmunotherapyinadvancedbreastcancer AT andoyuki acaseofapatientreceivingcombinationtherapywithpaclitaxelplusbevacizumabandadoptiveactivatedabtcellimmunotherapyinadvancedbreastcancer AT etomasatoshi acaseofapatientreceivingcombinationtherapywithpaclitaxelplusbevacizumabandadoptiveactivatedabtcellimmunotherapyinadvancedbreastcancer AT mimorikoshi acaseofapatientreceivingcombinationtherapywithpaclitaxelplusbevacizumabandadoptiveactivatedabtcellimmunotherapyinadvancedbreastcancer AT masudatakaaki caseofapatientreceivingcombinationtherapywithpaclitaxelplusbevacizumabandadoptiveactivatedabtcellimmunotherapyinadvancedbreastcancer AT nonamiatsushi caseofapatientreceivingcombinationtherapywithpaclitaxelplusbevacizumabandadoptiveactivatedabtcellimmunotherapyinadvancedbreastcancer AT tanakafumiaki caseofapatientreceivingcombinationtherapywithpaclitaxelplusbevacizumabandadoptiveactivatedabtcellimmunotherapyinadvancedbreastcancer AT andoyuki caseofapatientreceivingcombinationtherapywithpaclitaxelplusbevacizumabandadoptiveactivatedabtcellimmunotherapyinadvancedbreastcancer AT etomasatoshi caseofapatientreceivingcombinationtherapywithpaclitaxelplusbevacizumabandadoptiveactivatedabtcellimmunotherapyinadvancedbreastcancer AT mimorikoshi caseofapatientreceivingcombinationtherapywithpaclitaxelplusbevacizumabandadoptiveactivatedabtcellimmunotherapyinadvancedbreastcancer |